In 2018, 21.5 lakh tuberculosis (TB) cases were reported to the government, as compared to 18 lakh in 2017, an increase of 17 per cent in one year.
A new drug known as delamanid would be introduced in UP in the third quarter of the year, as per the central guidelines.
Tuberculosis (TB) remains the world's deadliest infectious disease although global efforts have averted an estimated 54 million tuberculosis (TB) deaths since 2000, the World Health Organization (WHO) warned.
Bedaquiline drug-resistant TB treatment regimen has come as a ray of hope for patients in the last few years and it renders patients non-infectious to other contacts much faster.
Researchers have developed a treatment that may help reverse chemical imbalances made to the brain by habitual drug use and could one day help recovering drug addicts avoid future drug use.
Turns out, higher dose of rifampin, an antibiotic to treat several types of bacterial infections, can kill more tuberculosis bacteria in sputum cultures without increasing the adverse effects of treatment.
Facts and new methods on treatment discussed at the 12th Interventional Pulmonology League (IPL 2018) organized by Institute of Pulmonology Medical Research & Development, in Mumbai.
Turns out, tolerating an infection without eliminating a pathogen is far more beneficial than simply killing it.
WHO says Tuberculosis is one of the top 10 causes of death globally resulting in 1.8 million deaths in 2016 alone.
The WHO TB statistics for India 2016 give an estimated incidence figure of 2.79 million cases.
If the human testing also shows positive results we can curb TB to a large extent.
The substance, called beta lactone EZ120, interferes with the formation of the bacterium's mycomembrane.
The government plans to eradicate TB by 2025 even though the WHO has set the target period as 2030.
As per the new policy, the patients will be given fixed drug combinations (FDCs), three or four drugs in a single pill daily -- being administered thrice a week till now.
Since 1997, under the RNTCP, patients were being given drugs thrice a week (the intermittent drug regimen).
A new ray of hope TB patients for better diagnosis and treatment.
Here's why you should think before you have antibiotics
First human study of a new TB drug
Why the TB drug regimen needs further clinical trials
Should we be cautious about new TB drug?
Something to spell relief -- future drugs of some deadly diseases like HIV can cancer can cost less and be more economical, thanks to new research in the world of medicine
TB patients in India suffer due to poor regulation of drugs
World Tuberculosis Day 2014 -- Drug-resistant TB on the rise in India
Indian government asked to regulate sale of TB drugs
In 2018, 21.5 lakh tuberculosis (TB) cases were reported to the government, as compared to 18 lakh in 2017, an increase of 17 per cent in one year.
A new drug known as delamanid would be introduced in UP in the third quarter of the year, as per the central guidelines.
Tuberculosis (TB) remains the world's deadliest infectious disease although global efforts have averted an estimated 54 million tuberculosis (TB) deaths since 2000, the World Health Organization (WHO) warned.
Bedaquiline drug-resistant TB treatment regimen has come as a ray of hope for patients in the last few years and it renders patients non-infectious to other contacts much faster.
Researchers have developed a treatment that may help reverse chemical imbalances made to the brain by habitual drug use and could one day help recovering drug addicts avoid future drug use.
Turns out, higher dose of rifampin, an antibiotic to treat several types of bacterial infections, can kill more tuberculosis bacteria in sputum cultures without increasing the adverse effects of treatment.
Facts and new methods on treatment discussed at the 12th Interventional Pulmonology League (IPL 2018) organized by Institute of Pulmonology Medical Research & Development, in Mumbai.
Turns out, tolerating an infection without eliminating a pathogen is far more beneficial than simply killing it.
WHO says Tuberculosis is one of the top 10 causes of death globally resulting in 1.8 million deaths in 2016 alone.
The WHO TB statistics for India 2016 give an estimated incidence figure of 2.79 million cases.
If the human testing also shows positive results we can curb TB to a large extent.
The substance, called beta lactone EZ120, interferes with the formation of the bacterium's mycomembrane.
The government plans to eradicate TB by 2025 even though the WHO has set the target period as 2030.
As per the new policy, the patients will be given fixed drug combinations (FDCs), three or four drugs in a single pill daily -- being administered thrice a week till now.
Since 1997, under the RNTCP, patients were being given drugs thrice a week (the intermittent drug regimen).
A new ray of hope TB patients for better diagnosis and treatment.
Here's why you should think before you have antibiotics
First human study of a new TB drug
Why the TB drug regimen needs further clinical trials
Should we be cautious about new TB drug?
Something to spell relief -- future drugs of some deadly diseases like HIV can cancer can cost less and be more economical, thanks to new research in the world of medicine
TB patients in India suffer due to poor regulation of drugs
World Tuberculosis Day 2014 -- Drug-resistant TB on the rise in India
Indian government asked to regulate sale of TB drugs
